RCGP calls for an end to the ‘vicious cycle’ of unfair funding for GP training

RCGP calls for an end to the ‘vicious cycle’ of unfair funding for GP training

July 10 2018 General practice should have the same level of funding as hospitals for hosting...

GMS ready reckoner published

GMS ready reckoner published

4 July 2018 A General Medical Services (GMS) Ready Reckoner has been produced giving GMS...

Scotland update Golden Hello arrangements for GPs

Scotland update Golden Hello arrangements for GPs

June 29 2018 The documentation for the Golden Hello scheme for GPs has been updated to make...

Extra £20m funding will go hand-in-hand with a new 10-year plan for the NHS

Extra £20m funding will go hand-in-hand with a new 10-year plan for the NHS

June 18 2018 Theresa May’s announcement of a £20.5 billion real-terms increase for...

  • RCGP calls for an end to the ‘vicious cycle’ of unfair funding for GP training

    RCGP calls for an end to the ‘vicious cycle’ of unfair funding for GP training

    Tuesday, 10 July 2018 09:39
  • GMS ready reckoner published

    GMS ready reckoner published

    Wednesday, 04 July 2018 15:22
  • Scotland update Golden Hello arrangements for GPs

    Scotland update Golden Hello arrangements for GPs

    Friday, 29 June 2018 15:11
  • Extra £20m funding will go hand-in-hand with a new 10-year plan for the NHS

    Extra £20m funding will go hand-in-hand with a new 10-year plan for the NHS

    Monday, 18 June 2018 17:31

abpi reception logoJuly 20 2015

Fifty pharmaceutical companies collectively paid an estimated £41 million to doctors, nurses and other healthcare professionals during 2014. In 2013, an estimated £38.5m was paid by 34 companies, and in 2012, £40m was paid by 35 companies.

The 2014 payments relate to 28,556 ‘relationships’ with healthcare professionals, says the Association of the British Pharmaceutical Industry, which has published the annual aggregated data for its member companies.

However from 2016, a new database showing individual payments and disclosures made by the pharmaceutical industry will come into place.

“This is the last year that aggregate payments will be disclosed in this way as, from June 30 2016, industry will be reporting payments made to individual, named, healthcare professionals, starting with payments made during 2015, on a searchable database managed by the ABPI,” said the Association.

“This new platform will include payments for categories of activity currently not disclosed in aggregate figures and signals industry’s commitment to increased transparency in its relationships with healthcare professionals and healthcare organisations.”

Dr Virginia Acha, ABPI’s Executive Director Research, Medical and Innovation said2015 “heralds the start of an era of even more openness when payments to individual healthcare professionals will be disclosed for a wider range of activities.

“We are currently engaging with representative bodies of healthcare professionals to explain industry’s commitment to increased transparency and we hope as many healthcare professional as possible will agree to their data being published on the new database in support of this increased transparency.”

Links:

ABPI announcement    

ABPI Disclosure of Payments    

Management News

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect them from cancer, the Department of Health and Social Care has announced.
July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...